Market Research Report

U.S. Market for Orthopedic Biomaterials 2012
cover Published by iData Research Inc.
Published Product code 239911
Content info 362 Pages
Price

Introduction

Abstract

The 2011 figures in the orthopedic biomaterials market show great promise for future performance of the orthopedic biomaterials market. To date there has been a multitude of products introduced to the market, with some becoming spectacular successes. Future growth for this market will be a result of continued improvements in product technology to meet the needs of patients as well as changes in healthcare reform and reimbursement. This comprehensive report covers a number of disciplines, including spinal surgery, sports medicine, tissue donation, and biotechnology. In each segment of this report, current market conditions are thoroughly examined and the behavior of each sub-segment over the forecast period is critically analyzed and cross-verified.

The Orthopedic biomaterials market includes:

  • bone graft substitutes,
  • growth factors,
  • machined allografts,
  • hyaluronic acid viscosupplementation,
  • resorbable fixation devices,
  • tendon grafts,
  • cartilage repair,
  • platelet and bone marrow concentration,
  • orthopedic stem cells and
  • emerging technologies

This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Table of Contents

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1 U.S. MARKET FOR ORTHOPEDIC BIOMATERIALS
  • 1.2 ORTHOPEDIC BIOMATERIAL MARKET GROWTH RATES
  • 1.3 BONE GRAFT SUBSTITUTE USAGE PER INDICATION
  • 1.4 MACHINED BONE ALLOGRAFT MARKET
  • 1.5 HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.6 RESORBABLE FIXATION DEVICE MARKET
  • 1.7 TENDON GRAFT MARKET
  • 1.8 CARTILAGE REPAIR MARKET
  • 1.9 PLATELET AND BONE MARROW CONCENTRATION MARKET
  • 1.10 ORTHOPEDIC STEM CELL MARKET
  • 1.11 LEADING COMPETITORS

RESEARCH METHODOLOGY

  • 2.1 RESEARCH SCOPE
  • 2.2 IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

U.S. ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW

  • 3.1 INTRODUCTION
    • 3.1.1 Growth Factors
    • 3.1.2 Bone Graft Substitutes
    • 3.1.3 Machined Bone Allografts
    • 3.1.4 Hyaluronic Acid Viscosupplementation
    • 3.1.5 Resorbable Fixation Devices
    • 3.1.6 Tendon Grafts
    • 3.1.7 Cartilage Repair
    • 3.1.8 Platelet and Bone Marrow Concentration
    • 3.1.9 Orthopedic Stem Cell Therapy
  • 3.2 MARKET ANALYSIS AND FORECAST
    • 3.2.1 Market by Segment
  • 3.2.2 Trend Analysis
  • 3.3 MARKET DRIVERS AND LIMITERS
    • 3.3.1 Market Drivers
  • 3.3.2 Market Limiters
  • 3.4 COMPETITIVE ANALYSIS
    • 3.4.1 Market Concentration
  • 3.5 MERGERS AND ACQUISITIONS
    • 3.5.1.1 Osteotech Acquired Distributorship of Harvest Technologies System
    • 3.5.1.2 Regeneration Technologies Merged with Tutogen Medical Inc
    • 3.5.1.3 NuVasive Acquired Osiris Therapeutics' OsteocelR Product
    • 3.5.1.4 NuVasive Acquired Cervitech
    • 3.5.1.5 Biomet Acquired Cartilix
    • 3.5.1.6 Alphatec Holdings Acquired Scient'x Groupe
    • 3.5.1.7 Anika Acquired Fidia Advanced Biopolymers
    • 3.5.1.8 Baxter International Acquired ApaTech
    • 3.5.1.9 Stryker Acquired Orthovita
    • 3.5.1.10 Olympus Biotech Acquired OP-1TM from Stryker
    • 3.5.1.11 Histogenics Acquired ProChon Biotech

GROWTH FACTOR MARKET

  • 4.1 INTRODUCTION
    • 4.1.1 Overview
    • 4.1.2 BMP-2 (Medtronic)
    • 4.1.3 BMP-7 (Olympus Biomaterials)
    • 4.1.4 Potential Complications
    • 4.1.5 Reimbursement
    • 4.1.6 Future Indications
  • 4.2 MARKET ANALYSIS AND FORECAST
  • 4.3 MARKET DRIVERS AND LIMITERS
    • 4.3.1 Market Drivers
    • 4.3.2 Market Limiters
  • 4.4 COMPETITIVE ANALYSIS
    • 4.4.1 Leading Competitors
    • 4.4.2 Potential Competitors

BONE GRAFT SUBSTITUTE MARKET

  • 5.1 INTRODUCTION
  • 5.2 MARKET SEGMENTATION
    • 5.2.1 Indications
      • 5.2.1.1 Spine
    • 5.2.1.2 Trauma
    • 5.2.1.3 Extremities
    • 5.2.2 Materials
      • 5.2.2.1 Autografts
      • 5.2.2.2 Standard Allografts
      • 5.2.2.3 Demineralized Bone Matrix
      • 5.2.2.4 Synthetics
      • 5.2.2.5 Xenografts
  • 5.3 PROCEDURES
    • 5.3.1 Total Procedures
    • 5.3.2 Spinal Procedures
  • 5.4 UNITS PER PROCEDURE
  • 5.5 MARKET OVERVIEW
    • 5.5.1 Market by Material
    • 5.5.2 Market by Indication
  • 5.6 MARKET ANALYSIS AND FORECAST
    • 5.6.1.1 Spinal Bone Graft Substitute Market
      • 5.6.1.2 Cervical Spinal Bone Graft Substitute Market
      • 5.6.1.3 Thoracolumbar Spinal Bone Graft Substitute Market
      • 5.6.1.4 Trauma Bone Graft Substitute Market
      • 5.6.1.5 Large Joint Reconstruction Bone Graft Substitute Market
      • 5.6.1.6 Foot Reconstruction Bone Graft Substitute Market
      • 5.6.1.7 Craniomaxillofacial Bone Graft Substitute Market
      • 5.6.1.8 Oncology Bone Graft Substitute Market
    • 5.6.2 Bone Graft Substitute Market by Material
    • 5.6.2.1 Allograft
      • 5.6.2.1.1 Total Allograft Market
      • 5.6.2.1.2 Spinal Allograft
        • 5.6.2.1.2.1 Cervical Spinal Allograft
        • 5.6.2.1.2.2 Thoracolumbar Spinal Allograft
      • 5.6.2.1.3 Trauma Allograft
        • 5.6.2.1.3.1 Non-Union Fracture Allograft Market
        • 5.6.2.1.3.2 Fresh-Fracture Allograft Market
      • 5.6.2.1.4 Joint Reconstruction Allograft
        • 5.6.2.1.4.1 Hip Reconstruction Allograft
        • 5.6.2.1.4.2 Knee Reconstruction Allograft
      • 5.6.2.1.5 Foot Reconstruction Allograft
      • 5.6.2.1.6 Craniomaxillofacial Allograft
      • 5.6.2.1.7 Oncology Allograft
    • 5.6.2.2 Demineralized Bone Matrices
      • 5.6.2.2.1 Total DBM Market
      • 5.6.2.2.2 Spinal DBM
        • 5.6.2.2.2.1 Cervical Spinal DBM
      • 5.6.2.2.2.2 Thoracolumbar Spinal DBM
      • 5.6.2.2.3 Trauma DBM
        • 5.6.2.2.3.1 Non-Union DBM
        • 5.6.2.2.3.2 Fresh-Fracture DBM
      • 5.6.2.2.4 Joint Reconstruction DBM
        • 5.6.2.2.4.1 Hip Reconstruction DBM
        • 5.6.2.2.4.2 Knee Reconstruction DBM
      • 5.6.2.2.5 Foot Reconstruction DBM
      • 5.6.2.2.6 Craniomaxillofacial DBM Market
      • 5.6.2.2.7 Oncology DBM
    • 5.6.2.3 Synthetic Bone Graft Substitute Market
      • 5.6.2.3.1 Total Synthetic Market
      • 5.6.2.3.2 Spinal Synthetic
        • 5.6.2.3.2.1 Cervical Synthetic
        • 5.6.2.3.2.2 Thoracolumbar Synthetic
      • 5.6.2.3.3 Trauma Synthetic
        • 5.6.2.3.3.1 Non-Union Fracture Synthetic
      • 5.6.2.3.3.2 Fresh Fracture Synthetic
      • 5.6.2.3.4 Joint Reconstruction Synthetic
        • 5.6.2.3.4.1 Hip Reconstruction Synthetic
        • 5.6.2.3.4.2 Knee Reconstruction Synthetic
      • 5.6.2.3.5 Foot Synthetic
      • 5.6.2.3.6 Craniomaxillofacial Synthetic
      • 5.6.2.3.7 Oncology Synthetic
  • 5.7 MARKET DRIVERS AND LIMITERS
    • 5.7.1 Market Drivers
      • 5.7.1.1 Standard Allograft Market
      • 5.7.1.2 DBM Market
      • 5.7.1.3 Synthetic Market
    • 5.7.2 Market Limiters
      • 5.7.2.1 Standard Allograft Market
      • 5.7.2.2 DBM Market
      • 5.7.2.3 Synthetic Market
  • 5.8 COMPETITIVE ANALYSIS
    • 5.8.1 Bone Graft Substitute Market
      • 5.8.1.1 Allograft Market
      • 5.8.1.2 DBM Market
      • 5.8.1.3 Synthetic Bone Graft Substitute Market

ORTHOPEDIC STEM CELL MARKET

  • 6.1 INTRODUCTION
  • 6.2 MARKET OVERVIEW
    • 6.2.1 Lineage
      • 6.2.1.1 Human Embryonic Stem Cells (hESC)
      • 6.2.1.2 Mesenchymal Stem Cells (MSC)
    • 6.2.2 Legislation
    • 6.2.3 Other Therapeutic Applications
  • 6.3 MARKET ANALYSIS AND FORECAST
    • 6.3.1 Total Market
      • 6.3.1.1 Lumbar Spine Stem Cell Market
      • 6.3.1.2 Cervical Spine Stem Cell Market
  • 6.4 MARKET DRIVERS AND LIMITERS
    • 6.4.1 Market Drivers
    • 6.4.2 Market Limiters
  • 6.5 COMPETITIVE ANALYSIS
    • 6.5.1 Leading Competitors
    • 6.5.2 Potential Competitors

MACHINED BONE ALLOGRAFT MARKET

  • 7.1 INTRODUCTION
    • 7.1.1 Approaches
      • 7.1.1.1 Anterior Lumbar Interbody Fusion (ALIF)
      • 7.1.1.2 Posterior Lumbar Interbody Fusion (PLIF)
      • 7.1.1.3 Transforaminal Lumbar Interbody Fusion (TLIF)
      • 7.1.1.4 Extreme Lateral Interbody Fusion (XLIF)
      • 7.1.1.5 Cervical
  • 7.2 PROCEDURES
  • 7.3 MARKET OVERVIEW
  • 7.4 MARKET FORECAST AND ANALYSIS
    • 7.4.1 ALIF Approach
    • 7.4.2 PLIF Approach
    • 7.4.3 TLIF Approach
    • 7.4.4 Cervical Machined Bone Allografts
  • 7.5 MARKET DRIVERS AND LIMITERS
    • 7.5.1 Market Drivers
    • 7.5.2 Market Limiters
  • 7.6 COMPETITIVE ANALYSIS

PLATELET AND BONE MARROW ASPIRATE CONCENTRATION MARKET

  • 8.1 INTRODUCTION
    • 8.1.1 Platelet Rich Plasma
    • 8.1.2 Bone Marrow Aspirate
  • 8.2 MARKET OVERVIEW
  • 8.3 MARKET ANALYSIS AND FORECAST
    • 8.3.1 Total Platelet Concentration Market
      • 8.3.1.1 Spinal Platelet Concentration Market
      • 8.3.1.2 Extremity and Sports Medicine Platelet Concentration Market
    • 8.3.2 Total Bone Marrow Aspirate Concentration Market
  • 8.4 MARKET DRIVERS AND LIMITERS
    • 8.4.1 Market Drivers
    • 8.4.2 Market Limiters
  • 8.5 COMPETITIVE ANALYSIS

TENDON GRAFT MARKET

  • 9.1 INTRODUCTION
    • 9.1.1 Repair Methods
      • 9.1.1.1 Bone-Patellar Tendon-Bone (BTB) Graft, ACL/PCL Surgery
      • 9.1.1.2 Soft Tissue Grafts
      • 9.1.1.3 Allograft Tendons
      • 9.1.1.4 Ligament and Tendon Synthetic Grafts
  • 9.2 PROCEDURES
  • 9.3 MARKET FORECAST AND ANALYSIS
  • 9.4 MARKET DRIVERS AND LIMITERS
    • 9.4.1 Market Drivers
    • 9.4.2 Market Limiters
  • 9.5 COMPETITIVE ANALYSIS

CARTILAGE REPAIR MARKET

  • 10.1 INTRODUCTION
    • 10.1.1 Methods for Cartilage Repair
  • 10.2 PROCEDURES
  • 10.3 MARKET ANALYSIS AND FORECAST
    • 10.3.1 Cartilage Repair Market
    • 10.3.2 Autologous Chondrocyte Implantation Market
    • 10.3.3 Osteochondral Allograft Market
    • 10.3.4 Meniscal Graft Market
  • 10.4 MARKET DRIVERS AND LIMITERS
    • 10.4.1 Market Drivers
    • 10.4.2 Market Limiters
  • 10.5 COMPETITIVE ANALYSIS
    • 10.5.1 Leading Competitors
    • 10.5.2 Emerging Competitors

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 11.1 INTRODUCTION
    • 11.1.1 Benefits of Viscosupplementation
    • 11.1.2 Synovial Fluid
    • 11.1.3 Product Types
      • 11.1.3.1 Single-Injection Products
      • 11.1.3.2 Three-Injection Cycle Products
      • 11.1.3.3 Three/Five-Injection Cycle Products
    • 11.1.4 Reimbursement
  • 11.2 MARKET OVERVIEW
  • 11.3 MARKET ANALYSIS AND FORECAST
    • 11.3.1 Total Market
      • 11.3.1.1 Single-Injection Hyaluronic Acid Viscosupplementation Market
      • 11.3.1.2 Three-Injection Cycle Hyaluronic Acid Viscosupplementation Market
      • 11.3.1.3 Five-Injection Cycle Hyaluronic Acid Viscosupplementation Market
  • 11.4 MARKET DRIVERS AND LIMITERS
    • 11.4.1 Market Drivers
    • 11.4.2 Market Limiters
  • 11.5 COMPETITIVE ANALYSIS

RESORBABLE FIXATION MARKET

  • 12.1 INTRODUCTION
    • 12.1.1 Materials
    • 12.1.2 Disadvantages Compared to Metal Fixation
    • 12.1.3 Indications and Product Descriptions
      • 12.1.3.1 Shoulder Fixation
      • 12.1.3.2 Knee Reconstruction
  • 12.2 MARKET OVERVIEW
  • 12.3 MARKET ANALYSIS AND FORECAST
    • 12.3.1 Resorbable Fixation Market
    • 12.3.2 ACL/PCL Resorbable Fixation Market
      • 12.3.2.1 Femoral Fixation
      • 12.3.2.2 Tibia Fixation Market
    • 12.3.3 Meniscal Resorbable Fixation Market
    • 12.3.4 Rotator Cuff Resorbable Fixation Market
    • 12.3.5 Labrum Repair Market
  • 12.4 MARKET DRIVERS AND LIMITERS
    • 12.4.1 Market Drivers
      • 12.4.1.1 Shoulder Fixation
      • 12.4.1.2 Knee Fixation
    • 12.4.2 Market Limiters
      • 12.4.2.1 Shoulder Fixation
      • 12.4.2.2 Knee Fixation
  • 12.5 COMPETITIVE ANALYSIS
    • 12.5.1 Leading Competitors
    • 12.5.2 Other Notable Competitors

ABBREVIATIONS

U.S. Market for Orthopedic Biomaterials 2012 published by iData Research Inc. in May 1, 2012. This report consists of 362 Pages and the price starts from US $ 6995.

The contents of this page may be different from the latest version. Please contact us for details.
Back to Top